Press release
Erectile Dysfunction Drugs Market Size, Erectile Dysfunction Drugsmarket Share, Erectile Dysfunction Drugsmarket Trends, Erectile Dysfunction Drugs Market Analysis, Erectile Dysfunction Drugs Market Outlook, Erectile Dysfunction Drugs Market Opportunity,
Erectile Dysfunction Drugs Market
Request for Sample of This Research Report @ https://bit.ly/2NXzatD
Top Key Players:-
Bayer AG
Pfizer
Eli Lilly & Co.
Vivus, Inc.
S.K. Chemicals Co. Ltd.
Dong-A Pharmaceutical Co. Ltd
Meda Pharmaceuticals
Apricus Biosciences
Make an inquiry before buying this report @ https://www.polarismarketresearch.com/industry-analysis/erectile-dysfunction-drugs-market/inquire-before-buying
According to a new study published by Polaris Market Research the global erectile dysfunction drugs market is anticipated to reach USD 2.63 billion by 2025. Impotence, also known as erectile dysfunction is the condition of sexual dysfunction where, during the sexual intercourse, men cannot maintain the erection. According to World Health Organization statement, for the emotional, physical and wellbeing of the individual, and to the economic and social development of countries and communities, sexual health is a fundamental thing. Erectile dysfunction affects the quality of life for both partners and patients and is connected with relationship difficulties.
Browse Full Report @ https://www.polarismarketresearch.com/industry-analysis/erectile-dysfunction-drugs-market/toc/
Erectile dysfunction is generally an age-related condition but can also be triggered by psychological factors. Cardiovascular diseases such as high blood pressure, clogged arteries etc., diabetes, hormonal insufficiency, chronic kidney disease, multiple sclerosis, injury to the penis, bladder, and pelvis, and neurological issues are the common factor which can cause erectile dysfunction. Moreover, sedentary lifestyle, smoking, excessive alcohol intake, obesity and consumption of drugs such as, antihypertensive drugs, antidepressant, recreational drugs, and psychotropic drugs are some other factors which are significantly contributing towards erectile dysfunction. Exercise, pharmacotherapy, well balanced and maintain lifestyle, penis implants, erection devices, and injections into penis are current treatment available to cure erectile dysfunction. Currently, oral PDE5 (phosphodiesterase type 5 inhibitors) is the first line drug therapy prescribed by physicians for erectile dysfunction.
The availability of oral drugs globally, and rising awareness about erectile dysfunction and sexual diseases is resulting in significant adoption of treatment globally. Moreover, rising number of referrals to secondary care and primary care consultations is expected to propel the growth of erectile dysfunctions drugs market over the forecast period. The increasing elderly population and high rate of chronic diseases such as kidney failure, diabetes, hypertension, hormonal imbalance, and neurological disorders are increasing demand for erectile dysfunction drugs globally.
About us Polaris Market Research
Polaris Market Research is a global market research and consulting company. We provide unmatched quality of offerings to our clients present globally. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities.
We mainly focus on aiding our customers with substantial competitive intelligence, helping them to secure a competitive advantage in the market and accomplish sustainable growth in different market domains. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavour to deliver value-added business solutions to our customers. Through dedicated qualitative and quantitative primary and secondary market research and consulting assignments, we adeptly formulate competitive strategies to address business challenges for our clients through analysing market trends and emerging technologies.
Contact us-
Mr. Neel
Corporate Sales, USA
Polaris Market Research
Phone: +1-646-568-9980
E-Mail: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Erectile Dysfunction Drugs Market Size, Erectile Dysfunction Drugsmarket Share, Erectile Dysfunction Drugsmarket Trends, Erectile Dysfunction Drugs Market Analysis, Erectile Dysfunction Drugs Market Outlook, Erectile Dysfunction Drugs Market Opportunity, here
News-ID: 1245965 • Views: โฆ
More Releases from Polaris Market Research & Consulting
Anorexiants Market Expected to Attain US$ 1,403.13 Million by 2032, Maintaining โฆ
Growing consciousness about the genesis and solutions of obesity, together with the internet's availability to a broader consumer base, is disposed to ignite the acquisition of weight management drugs. Based on drug class analysis, the catecholamine's segment witnesses the highest growth. By region, in 2023, North America dominated the market with the largest share.
๐๐๐ญ ๐๐ฑ๐๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐ฌ ๐จ๐ ๐๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.polarismarketresearch.com/industry-analysis/anorexiants-market/request-for-sample
๐๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐๐ซ๐๐ฌ๐ฌ๐๐ฌ:
โข The global anorexiants market was valuedโฆ
North America Hearing AID Market size of USD 14.48 Billion in 2032, at a CAGR 6. โฆ
Polaris Market Research has recently published its latest research report titled "North America Hearing AID Market by Product (Hearing AID Devices and Hearing Implant), Type (Conductive Hearing Loss and Sensorineural Hearing Loss), Patient, Technology - Forecast to 2032." The study reveals that the market is anticipated to grow at a CAGR of 6.0%, reaching a market size of USD 14.48 billion in 2032 from the value of USD 8.58 billionโฆ
Vehicle Armor Materials Market Valuation to Hit US$ 10.10 Billion by 2032, Showi โฆ
Global vehicle armor materials market size and share is currently valued at USD 5.98 billion in 2023 and is anticipated to generate an estimated revenue of USD 10.10 billion by 2032, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 6.2% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2024 - 2032
๐๐๐ข๐ง ๐๐ฆ๐ฆ๐๐๐ข๐๐ญ๐ ๐๐๐๐๐ฌ๐ฌ ๐ญ๐จ ๐๐ฎ๐ซ ๐๐ฑ๐๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ:โฆ
Buy Now Pay Later Market Hits Milestone - Projected at USD 80.52 Billion By 2032 โฆ
Polaris Market Research's recent research demonstrates that the Buy Now Pay Later Market is expected to witness a steady CAGR of 29.20% during the forecast period. The market was valued at USD 8.05 billion in 2023 and is expected to grow to USD 80.52 billion by 2032. Growth can be linked to clients' strong preference for flexible payment options.
๐๐๐ญ ๐๐ฑ๐๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐ฌ ๐จ๐ ๐๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.polarismarketresearch.com/industry-analysis/buy-now-pay-later-market/request-for-sample
Buy now, pay later,โฆ
More Releases for Erectile
Global Erectile Dysfunction Devices Market Report
As per GME studies, on the Global Erectile Dysfunction Devices Market, it is analyzed that the market will grow at a CAGR of 6.5%. Erectile dysfunction incidence increases with growing age, about 5-10% of men under 40 years are the possible suspects for the dysfunctionality. This is projected to drive the ED device market in the coming years also. Raising the aforementioned disease prevalence and the growing percentage of tobaccoโฆ
50 Open Clinical Studies Presently, To Treat Erectile Dysfunction To Boost The E โฆ
Erectile dysfunction is known as the medical condition of penis, a recurrent inability of a man to reach and/or to maintain a penile erection sufficient for/during sexual activities. It is most probably an age-related factor, progressive condition, affecting some level of disorder (mild, moderate or severe) in about 50% of men aged 40-70 years, and with the increase in the age, severity of erectile dysfunction also increase with a ratioโฆ
Erectile Dysfunction Market Industry Forecast till 2024
Erectile dysfunction is known as the medical condition of penis, a recurrent inability of a man to reach and/or to maintain a penile erection sufficient for/during sexual activities. It is most probably an age-related factor, progressive condition, affecting some level of disorder (mild, moderate or severe) in about 50% of men aged 40-70 years, and with the increase in the age, severity of erectile dysfunction also increase with aโฆ
Erectile Dysfunction: A Prominent Age Related Disorder
Erectile dysfunction is known as the medical condition of penis, a recurrent inability of a man to reach and/or to maintain a penile erection sufficient for/during sexual activities. It is most probably an age-related factor, progressive condition, affecting some level of disorder (mild, moderate or severe) in about 50% of men aged 40-70 years, and with the increase in the age, severity of erectile dysfunction also increase with aโฆ
Erectile Dysfunction - Pipeline Review, H2 2017
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as โErectile Dysfunction - Pipeline Review, H2 2017โ.ย Erectile dysfunction, or ED, is the inability of a man to have an erection hard enough to have sexual intercourse. It can also be known as impotence.
Request For Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1246564
The predisposing factors include tobacco usage, overweight, injuries, drug and alcohol use and medications, including antidepressants,โฆ
Erectile Dysfunction - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title
Erectile Dysfunction - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Erectile Dysfunction - Pipeline Review, H1 2017, provides an overview of the Erectile Dysfunction (Male Health) pipeline landscape.
Erectile dysfunction, or ED, is the inability of a man to have an erection hard enough to haveโฆ
